… These patients with type II diabetes constitute a large percentage of patients with advanced
cardiovascular disease. They have a more aggressive form of arterial disease than do their …

… in patients with coronary artery disease. Additionally, diminished nitric oxide bioactivity
may facilitate vascular inflammation that could lead to oxidation of lipoproteins and foam cell …

… arterial disease of the extremities, myocardial infarction, and stroke. A hallmark of diabetic
vascular disease is … Reduced endothelium-mediated vasodilation has been found in arteries …

… The aims of this study were to examine plasma NOx in patients with coronary artery disease
(CAD) and to assess the association between plasma NOx concentrations and the three …

… In patients with coronary artery disease and impairment ofendothelial vasodilatory
function, increases in blood flow through the diseasedcoronary artery cause a paradoxical …

… , and defective nitric oxide metabolite physiology and … and nitric oxide metabolism plays an
important role in modulating functional and pathophysiological responses during this disease…

… highly significant relation with coronary artery disease revealing the interrelation between
… artery disease. The role of oxidative stress in the development of coronary artery disease is …

… Objectives: To analyse the role of nitric oxide (NO) in peripheral arterial disease (PAD) and
its association with inflammation and brachial artery flow-mediated dilation (BAFMD) as an …

… Nitric oxide (NO), a potent vasodilator produced by endothelial cells, is reduced in patients
with peripheral arterial disease (PAD), but the mechanism has not been fully elucidated. …

… Background: Endothelial nitric oxide synthase (eNOS) could be a candidate gene for coronary
artery disease (CAD). This study investigated the relationship of the eNOS Glu 298 →Asp …